Re: Error Message from NONMEM :: MINIMIZATION TERMINATED (ERROR=136)
From:Nick Holford
Subject:Re: [NMusers] Error Message from NONMEM :: MINIMIZATION TERMINATED (ERROR=136)
Date:Thu, 19 Sep 2002 09:05:45 +1200
Partha,
The standard (and IMHO usually unhelpful) suggestion it to check the structure of
your model for errors. This may also involve considering posteriori non-identifiability because the
data does not really let you estimate some parameter such as between subject variability. This
leads to a KISS (Keep It Simple Stupid) approach to model building that may throw
the baby out with the bathwater.
I find that this typically happens when the model building is getting really interesting and I am
learning something new about the system I am trying to describe. I judge the usefulness of the model
(remembering George Box) by its ability to describe the data rather than some arbitrary numerical
criterion such as significant digits e.g. I am currently working on a model describing the placebo
response in depression. Only the simplest model converges and runs the covariance step.
More complex and informative models visibly fit the data better when I look at time courses of
HAMD score but typically fail to minimize (although I can sometimes get at least 3 sig digs by
using SIGDIG=4 on $ESTIMATION).
I rationalize this by saying that learning via modelling happens at the bleeding edge of the data.
We are trying to discover weak but potentially important signals (like the Hubble telescope recent
discovery of medium sized black holes http://oposite.stsci.edu/pubinfo/pr/2002/18/) that are buried
in the data. Confirming the obvious stuff (like sun, moon, planets) is visible without NONMEM -- that's
what statisticians do in their analyses. It is therefore no surprise that the criteria that give
statisticians a warm and fuzzy feeling (like asymptotic SEs) are not always discernible (or
believable) when trying to extract meaning from experiments not expicitly designed to discover new things.
In the particular example you show below the ETABAR estimates do seem to be pathologically different
from zero so trying a different between subject variability model may help e.g. use (1+ETA) instead
of exp(ETA) if it is possible that the parameter can have different signs in different individuals.
Nick
Nick Holford, Divn Pharmacology & Clinical Pharmacology
University of Auckland, 85 Park Rd, Private Bag 92019, Auckland, New Zealand
email:n.holford@auckland.ac.nz tel:+64(9)373-7599x6730 fax:373-7556
http://www.health.auckland.ac.nz/pharmacology/staff/nholford/
___________________________________